Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1,5-Isoquinolinediamine, 6-methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]-N1-[3-(trifluorometho... | 2274819-46-2 | 97.1% | 528.49 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY11194050MG

Encompass_Preferred

LUT014 is a topical BRAF inhibitor designed to address radiation-induced skin damage. It acts by inhibiting BRAF kinase and regulating the MAPK/ERK signaling pathway, promoting the repair and regeneration of damaged skin cells without passing the blood-brain barrier. It is particularly studied for treating radiation dermatitis, especially in breast cancer radiotherapy.

  • Topical BRAF inhibitor.
  • Inhibits BRAF kinase and activates MAPK/ERK signaling.
  • Promotes proliferation of epidermal keratinocytes.
  • Repairs skin barrier damage caused by radiation.
  • Alleviates inflammatory responses.
  • Independent of RAS signaling.
  • Accelerates repair and regeneration of damaged skin cells.
  • Suitable for studying radiation dermatitis.
  • Light yellow to yellow solid appearance.
  • Storage at 4°C, protected from light.
  • In solvent, store at -80°C for 6 months or -20°C for 1 month, protected from light.

Catalog No. 50-004-39499


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.